Summit Therapeutics - ADR Peer Comparison
$16.76
As on 02-Oct-2026 16:21EDT
Market cap
$13,366 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
20.8
Div. Yield
0 %
$16.76
As on 02-Oct-2026 16:21EDT
Market cap
$13,366 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
20.8
Div. Yield
0 %